Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Fink

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
The Journal of Pharmacology and Experimental Therapeutics|March 13, 1998
Antihypertensive and natriuretic effects of CGS 30440, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase 24.11R E Chatelain, R D Ghai, A J Trapani, et al.
Bioorganic & Medicinal Chemistry Letters|September 15, 2000
Design and synthesis of potent thiol-based inhibitors of endothelin converting enzyme-1C A Fink, M Moskal, F Firooznia, et al.
Journal of the American College of Cardiology|November 15, 1994
Early angiography cannot predict postthrombolytic coronary reocclusion: observations from the GUSTO angiographic study. Global Utilization of Streptokinase and t-PA for Occluded Coronary ArteriesJ S Reiner, C F Lundergan, M van den Brand, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2001
Synthesis and biological activity of novel potent endothelin-converting enzyme-1 inhibitorsF Firooznia, C Gude, K Chan, et al.
Molecular Imaging and Biology|August 23, 2022
Detecting and Locating the Site of Local Relapse Using <sup>18</sup>F-PSMA-1007 Imaging After Primary Treatment of 135 Prostate Cancer Patients-Potential Impact on PSMA-Guided Radiation TherapyS A Koerber, R C Kroener, K Dendl, et al.
Clinical and Translational Radiation Oncology|April 8, 2024
Stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer - Acute toxicity and patient-reported outcomes in the prospective, multicenter <i>SMILE</i> phase II trialC A Fink, J Ristau, C Buchele, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
The Journal of Pharmacology and Experimental Therapeutics|March 13, 1998
Antihypertensive and natriuretic effects of CGS 30440, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase 24.11R E Chatelain, R D Ghai, A J Trapani, et al.
Bioorganic & Medicinal Chemistry Letters|September 15, 2000
Design and synthesis of potent thiol-based inhibitors of endothelin converting enzyme-1C A Fink, M Moskal, F Firooznia, et al.
Journal of the American College of Cardiology|November 15, 1994
Early angiography cannot predict postthrombolytic coronary reocclusion: observations from the GUSTO angiographic study. Global Utilization of Streptokinase and t-PA for Occluded Coronary ArteriesJ S Reiner, C F Lundergan, M van den Brand, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2001
Synthesis and biological activity of novel potent endothelin-converting enzyme-1 inhibitorsF Firooznia, C Gude, K Chan, et al.
Molecular Imaging and Biology|August 23, 2022
Detecting and Locating the Site of Local Relapse Using <sup>18</sup>F-PSMA-1007 Imaging After Primary Treatment of 135 Prostate Cancer Patients-Potential Impact on PSMA-Guided Radiation TherapyS A Koerber, R C Kroener, K Dendl, et al.
Clinical and Translational Radiation Oncology|April 8, 2024
Stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer - Acute toxicity and patient-reported outcomes in the prospective, multicenter <i>SMILE</i> phase II trialC A Fink, J Ristau, C Buchele, et al.
Pageof 2